“Prescription drug prices are out of control,” wrote AHA President and CEO Rick Pollack and America’s Health Insurance Plans President and CEO Marilyn Tavenner in a Dec. 31 OpEd in The Hill. “The average annual cost for one specialty medication to treat a chronic condition is now more than what most families earn in a year. Big Pharma could solve the problem by committing to more rational and sustainable pricing models. Instead, for the last year, Big Pharma has chosen to point the finger at everyone else, and their decision to engage in a blame game is a tacit admission that drug prices are, in fact, too high.” To read the full column, click here.

Related News Articles

Headline
Two experts from AdventHealth discuss how its “Be a Mindleader” campaign is leading the way to improving adolescent mental health by helping parents and kids…
Headline
The Centers for Medicare & Medicaid Services May 3 announced the opening of the comment period for the Inflation Reduction Act’s Medicare Drug Price…
Headline
The departments of Health and Human Services, Labor, and the Treasury May 1 released a new process for resubmitting disputes under the No Surprises Act…
Headline
As part of AHA’s recognition of Mental Health Awareness Month in May, Rebecca Chickey, AHA’s senior director for behavioral health services, writes about the “…
Headline
AHA submitted a statement to the House Energy and Commerce Subcommittee on Health for a hearing April 30 on proposed legislation to address Medicaid access and…
Blog
Language not only describes what we think, but shapes how we think. Many of us remember terms that have fallen out of fashion or even have been deemed…